Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.54 |
| ▸ | TERT | O14746 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RAD52 | P43351 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10743106 | 0.85 | JAK2 (0.46) | JAK2POLBALDH1A1LMNAGAA | |
| SCHEMBL18986860 | 0.83 | JAK2 (0.49) | JAK2KDM4EALDH1A1GAAPARP1 | |
| Propionic Acid SCHEMBL8573908 | 0.79 | JAK2 (0.47) | JAK2POLBKDM4EALDH1A1LMNA | |
| SCHEMBL6701755 | 0.79 | JAK2 (0.43) | JAK2POLBRAD52KDM4EGLA | |
| Alcohol SCHEMBL5925469 | 0.79 | JAK2 (0.43) | JAK2POLBRAD52KDM4EALDH1A1 | |
| SCHEMBL5032885 | 0.78 | ELANE (0.43) | JAK2POLBLMNAKMT2APDPK1 | |
| SCHEMBL9603146 | 0.77 | SLC6A4 (0.44) | JAK2 | |
| SCHEMBL311169 | 0.76 | JAK2 (0.41) | JAK2POLBRAD52KDM4EALDH1A1 | |
| SCHEMBL17670057 | 0.76 | JAK2 (0.40) | JAK2POLBRAD52KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL9037659 | 0.75 | JAK2 (0.41) | JAK2POLBRAD52KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021116420-A1 | USE OF TLR7 AND/OR TLR8 AGONISTS FOR THE TREATMENT OF LEPTOSPIROSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-06-17 | — | — | WO | disclosed |
| EP-3294295-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS IN PATIENTS SUFFERING FROM CIRRHOSIS | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2018-03-21 | — | — | EP | disclosed |
| EP-3097416-A2 | METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-11-30 | — | — | EP | disclosed |
| WO-2016180945-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS IN PATIENTS SUFFERING FROM CIRRHOSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016180852-A1 | METHODS FOR PREPARING ANTIGEN-SPECIFIC T CELLS FROM AN UMBILICAL CORD BLOOD SAMPLE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-11-17 | — | — | WO | disclosed |
| EP-3024476-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-06-01 | — | — | EP | disclosed |
| WO-2015110397-A2 | METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2015-07-30 | — | — | WO | disclosed |
| WO-2015011254-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2015-01-29 | — | — | WO | disclosed |
| WO-2008004992-A2 | TRANSDERMAL FORMULATIONS CONTAINING HEPATITIS C VIRUS IMMUNOGENS AND AN ETHOXYLATED OIL | TRIPEP AB (SE) | 2008-01-10 | — | — | WO | disclosed |
| EP-1819364-A2 | IMMUNOMODULATORY COMPOSITIONS, COMBINATIONS AND METHODS | 3M Innovative Properties Company (US) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006063072-A2 | IMMUNOMODULATORY COMPOSITIONS, COMBINATIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006029223-A2 | METHOD FOR STIMULATING THE IMMUNE RESPONSE OF NEWBORNS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2006-03-16 | — | — | WO | disclosed |